BMJ Group Retina Logo
BMJ Group Retina Logo

BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought

May be time to reassess use of PARP inhibitor drugs in these patients, say researchers Findings pave way for refining genetic testing and personalised treatment in prostate cancer Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate ...

2025-02-25T17:36:11+00:0025 February 2025|BMJ Oncology, Press release|

Gene signature shows promise to improve survival for breast cancer patients

First trial to show feasibility of gene signature to tailor treatment for high risk patients  Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published by The BMJ today. Triple negative breast ...

2024-10-24T11:23:53+00:0024 October 2024|Press release, The BMJ|

Around 40% of postmenopausal hormone positive breast cancers linked to excess body fat

Proportion much higher than that assessed with widely used measure (BMI) Real impact of obesity on risk has likely been underestimated, say researchers Around 40% of postmenopausal hormone positive breast cancer cases may be linked to excess body fat, suggests Spanish research published online in the Journal of Epidemiology & Community ...

20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

It complements traditional pain relief and broadens repertoire of options, say researchers Twenty minutes of mindful breathing, which focuses a person’s attention on their breath, can rapidly reduce the intensity and unpleasantness of cancer pain and relieve the associated anxiety, suggest the findings of a small comparative study, published online ...

Modest rise in UK cancer cases but substantial decline in deaths over last 25 years

Results are, overall, positive and reassuring, but further work is needed to address rise in some less common types of cancer, say experts Cases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also ...

2024-06-04T10:23:52+00:0014 March 2024|Press release, The BMJ|

Significant proportion of cancer drugs lack proof of added benefit

Particularly those approved through “fast track” pathways Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited (“fast track”) pathways, finds a study published by The BMJ today. And despite pharmaceutical industry claims that high drug prices are ...

2024-06-04T10:24:26+00:0029 February 2024|Press release, The BMJ|

Increase in annual cardiorespiratory fitness by 3%+ linked to 35% lower prostate cancer risk

Encourage men to improve fitness to help lower risk of getting the disease, say researchers An increase in annual cardiorespiratory fitness by 3% or more is linked to a 35% lower risk of developing, although not dying from, prostate cancer, suggests research published online in the British Journal of Sports Medicine. ...

New study assesses long term risk of invasive breast cancer after pre-invasive disease

Increased risk lasts for at least 25 years after diagnosis, suggesting longer term monitoring is needed Women who are diagnosed with ductal carcinoma in situ (DCIS) outside the NHS breast screening programme are around four times as likely to develop invasive breast cancer and to die from breast cancer than ...

2024-06-04T10:23:21+00:0025 January 2024|Press release, The BMJ|

Sex-specific panel of 10 proteins can pick up 18 different early stage cancers

Could kickstart new generation of screening tests for early cancer detection, say researchers A sex-specific panel of 10 proteins can pick up 18 different early stage cancers, representing all the major organs of the human body, finds a proof of concept study published in the open access journal BMJ Oncology.  The ...

2024-06-04T10:23:22+00:0010 January 2024|BMJ Oncology, Press release|

Actively monitoring cervical lesions linked to heightened long term risk of cervical cancer

Absolute risk of cervical cancer remains low, but results show importance of regular checks for women having active surveillance Actively monitoring abnormal cells (lesions) that line the cervix rather than removing them straight away is associated with an increased long term risk of cervical cancer, suggests a study published by The ...

2024-06-04T10:23:24+00:0030 November 2023|Press release, The BMJ|
Go to Top